Association between migraine and the G1246A polymorphism in the hypocretin receptor 2 gene

Headache

Volumn 47, Issue 8, 2007, Pages 1195-1199

  Schürks, Markus ^a,f   Limmroth, Volker ^a,b   Geissler, Ingrid ^e   Tessmann, Grietje ^e   Savidou, Irini ^a   Engelbergs, Jörg ^a   Kurth, Tobias ^c,d   Diener, Hans Christoph ^a   Rosskopf, Dieter ^e  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF GREIFSWALD   (Germany)

^f UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Association; HCRTR2 polymorphism; Hypocretin system; Migraine

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPOCRETIN RECEPTOR 2 GENE; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PRIORITY JOURNAL;

ADULT; ALANINE; CHI-SQUARE DISTRIBUTION; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLYCINE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; POLYMORPHISM, GENETIC; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE; RETROSPECTIVE STUDIES;

EID: 34648821297     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2007.00863.x     Document Type: Article

References (29)

1. Montagna P. Molecular genetics of migraine headaches: A review. Cephalalgia. 2000 20:3 14.
2. Wessman M, Kaunisto MA, Kallela M, Palotie A. The molecular genetics of migraine. Ann Med. 2004 36:462 473.
3. Goadsby PJ, Lipton RB, Ferrari MD. Migraine - Current understanding and treatment. N Engl J Med. 2002 346:257 270.
4. May A. Cluster headache: Pathogenesis, diagnosis, and management. Lancet. 2005 366:843 855.
5. Headache Classification Committee of The International Headache Society. The International classification of headache disorders, 2nd edn. Cephalalgia. 2004 24:1 195.
6. May A, Bahra A, Büchel C, Frackowiak RSJ, Goadsby PJ. Hypothalamic activation in cluster headache attacks. Lancet. 1998 352:275 278.
7. Sakurai T, Amemiya A, Ishii M, et al Orexins and orexin receptors: A family of hypothalamic neuropeptides and G-protein coupled receptors that regulate feeding behavior. Cell. 1998 92:573 585.
8. De Lecea L, Kilduff TS, Peyron C, et al The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA. 1998 95:322 327.
9. Overeem S, Scammell TE, Lammers GJ. Hypocretin/orexin and sleep: Implications for the pathophysiology and diagnosis of narcolepsy. Curr Opin Neurol 2002 15:739 745.
10. Bartsch T, Levy MJ, Knight YE, Goadsby PJ. Differential modulation of nociceptive dural input to [hypocretin] orexin A and B activation in the posterior hypothalamic area. Pain. 2004 109:367 378.
11. Rainero I, Gallone S, Valfrè W, et al A polymorphism of the hypocretin receptor 2 gene is associated with cluster headache. Neurology. 2005 63:1286 1288.
12. Schürks M, Kurth T, Geissler I, Tessmann G, Diener HC, Rosskopf D. Cluster headache is associated with the G1246A polymorphism in the hypocretin receptor 2 gene. Neurology. 2006 66:1917 1919.
13. Baumber L, Sjöstrand C, Leone M, et al A genome-wide scan and HCRTR2 candidate gene analysis in a European cluster headache cohort. Neurology. 2006 66:1888 1893.
14. Bingham S, Davey PT, Babbs AJ, et al Orexin-A, an hypothalamic peptide with analgesic properties. Pain. 2001 92:81 90.
15. Holland PR, Akerman S, Goadsby PJ. Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception. J Pharmacol Exp Ther. 2005 315:1380 1385.
16. Peres MF, Sanchez del Rio M, Seabra S, et al Hypothalamic involvement in chronic migraine. J Neurol Neurosurg Psychiatry. 2001 71:747 751.
17. Dergacheva O, Wang X, Huang ZG, et al Hypocretin-1 (orexin-A) facilitates inhibitory and diminishes excitatory synaptic pathways to cardiac vagal neurons in the nucleus ambiguus. J Pharmacol Exp Ther. 2005 314:1322 1327.
18. Mignot E, Taheri S, Nishino S. Sleeping with the hypothalamus: Emerging therapeutic targets for sleep disorders. Nat Neurosci. 2002 5:1071 1075.
19. Weiller C, May A, Limmroth V, et al Brain stem activation in spontaneous human migraine attacks. Nat Med. 1995 1:658 660.
20. Bahra A, Matharu MS, Büchel C, Frackowiak RSJ, Goadsby PJ. Brain stem activation specific to migraine headache. Lancet. 2001 357:1016 1017.
21. Dahmen N, Querings K, Grun B, Bierbrauer J. Increased frequency of migraine in narcoleptic patients. Neurology. 1999 52:1291 1293.
22. Dahmen N, Kasten M, Wieczorek S, Gencik M, Epplen JT, Ullrich B. Increased frequency of migraine in narcoleptic patients: A confirmatory study. Cephalalgia. 2003 23:14 19.
23. Baumann CR, Bassetti CL. Hypocretins (orexins) and sleep-wake disorders. Lancet Neurol. 2005 4:673 682.
24. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgia, and facial pain. Cephalalgia. 1988 8:1 96.
25. Bird TD, Jarvik GP, Wood NW. Genetic association studies: Genes in search of diseases. Neurology. 2001 57:1153 1154.
26. Dora B. Migraine with cranial autonomic features and strict unilaterality. Cephalalgia. 2003 23:561 562.
27. Evans RW, Bahra A. Migraine and cluster headache: Coexistence, laterality, and gender. Headache. 2004 44:186 188.
28. Stewart WF, Linet MS, Celentano DD, Van Natta M, Ziegler D. Age and sex-specific incidence rates of migraine with and without visual aura. Am J Epidemiol. 1991 134:1111 1120.
29. Lipton RL, Bigal ME. Migraine: Epidemiology, impact, and risk factors for progression. Headache. 2005 45 (Suppl. 1 S3 S13.